XOMA Corporation (XOMA) Social Stream
XOMA CORP (XOMA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering XOMA CORP.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 24 months, XOMA's average price target has gone up $23.
Over the past 31 weeks, XOMA's average upside potential has been 219.4%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
XOMA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 31 months, XOMA's average broker recommendation rating improved by 1.33.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- XOMA CORP's number of analysts covering the stock is greater than 23.18% of all US stocks.
- In the context of stocks in the small market cap category, XOMA CORP's average analyst price target is greater than 381.88% of them.
- In terms of how XOMA CORP fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 79.46% of that group.
- In the context of stocks in the small market cap category, XOMA CORP's upside potential (average analyst target price relative to current price) is greater than 284.52% of them.
In the Pharmaceutical Products industry, CDMO, TXMD, and PLRX are the three stocks most similar to XOMA CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is XOMA a Buy, Hold or Sell? See the POWR Ratings now!